Remedy Plan Therapeutics is a small molecule therapeutics start-up company transforming the field of NAMPT inhibition, with a pioneering approach that allows for hyperbolic inhibition of NAMPT that is highly tunable. Remedy’s groundbreaking mechanism of action, which provides NAMPT inhibition without severe on-target toxicity, unlocks opportunities to treat a range of diseases caused by NAMPT dysregulation. We are advancing a robust pipeline of tunable NAMPT inhibitors, to address solid tumors, hematologic malignancies, obesity, and autoimmune disorders.
Remedy's lead asset is RPT1G. With a favorable efficacy and tolerability profile, RPT1G will be advancing to the clinic in 2024.
Company Details
- Employees
- 14
- Founded
- -
- Address
- ., Gaithersburg,md,united States
- Phone
- 240-459-3985
- gr****@****lan.com
- Industry
- Biotechnology
- Website
- https://remedyplan.com
- Keywords
- Cancer Drug Development, Biotechnology, Cancer Containment Therapy, Cancer Stem Cells, NAMPT inhibition.
- HQ
- Gaithersburg, MD
Remedy Plan Therapeutics Questions
Remedy Plan Therapeutics's helpline number is 240-459-3985
Remedy Plan Therapeutics's website is https://remedyplan.com
Remedy Plan Therapeutics's LinkedIn profile is https://www.linkedin.com/company/remedy-plan
Remedy Plan Therapeutics has
14 employees.
View email and phone details for 14
employees at Remedy Plan Therapeutics.
Remedy Plan Therapeutics's industry is
Biotechnology
Remedy Plan Therapeutics's top competitors are
Milliporesigma,
Therini Bio, Inc.,
Mantle,
Neuroene Therapeutics,
Verimmune,
Medcura, Inc.,
Charcot-Marie-Tooth Association,
Stylus Medicine,
Intrepid Labs,
Azafaros B.v..
Remedy Plan Therapeutics's support email address is greg@remedyplan.com
Remedy Plan Therapeutics's categories are Biotechnology
Remedy Plan Therapeutics's founding year is 2016
